InfuSystem Holdings, Inc. (INFU)

US — Healthcare Sector
Peers: ELMD  IRIX  JYNT  MLSS 

Automate Your Wheel Strategy on INFU

With Tiblio's Option Bot, you can configure your own wheel strategy including INFU - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol INFU
  • Rev/Share 6.6723
  • Book/Share 2.6012
  • PB 3.6945
  • Debt/Equity 0.5584
  • CurrentRatio 2.1941
  • ROIC 0.1461

 

  • MktCap 196293860.0
  • FreeCF/Share 1.0046
  • PFCF 9.3198
  • PE 39.7229
  • Debt/Assets 0.302
  • DivYield 0
  • ROE 0.0911

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 3
  • P/B Score 3
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation INFU Roth Capital -- Buy -- $12 July 22, 2025
Initiation INFU B. Riley Securities -- Buy -- $13 Sept. 26, 2024

News

Grab These 4 Stocks With Solid Net Profit Margins to Boost Returns
CENX, GLDD, INFU, TILE
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Boost your portfolio with GLDD, INFU, TILE and CENX, each showing strong net profit margins and rising EPS estimates.

Read More
image for news Grab These 4 Stocks With Solid Net Profit Margins to Boost Returns
4 Medical Product Stocks to Watch From a Challenging Industry
BLFS, INFU, MRMD, NVST
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Negative

The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.

Read More
image for news 4 Medical Product Stocks to Watch From a Challenging Industry
Are You Looking for a Top Momentum Pick? Why InfuSystems Holdings, Inc. (INFU) is a Great Choice
INFU
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive

Does InfuSystems Holdings, Inc. (INFU) have what it takes to be a top stock pick for momentum investors? Let's find out.

Read More
image for news Are You Looking for a Top Momentum Pick? Why InfuSystems Holdings, Inc. (INFU) is a Great Choice
Recent Price Trend in InfuSystems Holdings (INFU) is Your Friend, Here's Why
INFU
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive

InfuSystems Holdings (INFU) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Read More
image for news Recent Price Trend in InfuSystems Holdings (INFU) is Your Friend, Here's Why
Why InfuSystems Holdings (INFU) Might be Well Poised for a Surge
INFU
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive

InfuSystems Holdings, Inc. (INFU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Read More
image for news Why InfuSystems Holdings (INFU) Might be Well Poised for a Surge
Can InfuSystems Holdings (INFU) Climb 79.52% to Reach the Level Wall Street Analysts Expect?
INFU
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive

The average of price targets set by Wall Street analysts indicates a potential upside of 79.5% in InfuSystems Holdings (INFU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Read More
image for news Can InfuSystems Holdings (INFU) Climb 79.52% to Reach the Level Wall Street Analysts Expect?
Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
INFU
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now?
InfuSystem Holdings, Inc. (INFU) Q2 2025 Earnings Call Transcript
INFU
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Neutral

InfuSystem Holdings, Inc. (NYSE:INFU ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Barry G. Steele - Executive VP & CFO Carrie A.

Read More
image for news InfuSystem Holdings, Inc. (INFU) Q2 2025 Earnings Call Transcript
Is the Options Market Predicting a Spike in InfuSystems Holdings Stock?
INFU
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors need to pay close attention to InfuSystems Holdings stock based on the movements in the options market lately.

Read More
image for news Is the Options Market Predicting a Spike in InfuSystems Holdings Stock?
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
INFU
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Negative

InfuSystems Holdings, Inc. (INFU) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.05 per share a year ago.

Read More
image for news InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025
INFU
Published: May 01, 2025 by: Business Wire
Sentiment: Neutral

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025.

Read More
image for news InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025

About InfuSystem Holdings, Inc. (INFU)

  • IPO Date 2007-12-27
  • Website https://www.infusystem.com
  • Industry Medical - Instruments & Supplies
  • CEO Richard Armand DiIorio
  • Employees 502

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.